Kiniksa Pharmaceuticals Ltd (KNSA) — Net Asset Quality Index
Kiniksa Pharmaceuticals Ltd (KNSA) has a Net Asset Quality Index of 73.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $896.11 Million minus total liabilities of $241.96 Million yields net assets of $654.15 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Kiniksa Pharmaceuticals Ltd carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Kiniksa Pharmaceuticals Ltd Net Asset Quality Index Over Time (2016–2025)
This chart shows how Kiniksa Pharmaceuticals Ltd's Net Asset Quality Index has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the index stands at 73.0%, representing net assets of $654.15 Million against total assets of $896.11 Million USD. For live market cap and overall valuation, see how much is Kiniksa Pharmaceuticals Ltd worth.
Annual Net Asset Quality Index for Kiniksa Pharmaceuticals Ltd (2016–2025)
The table below presents the year-by-year Net Asset Quality Index for Kiniksa Pharmaceuticals Ltd from 2016 to 2025, covering 10 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check KNSA strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 74.3% | $567.61 Million | $763.63 Million | $196.03 Million | ▼ -1.2 pp |
| 2024 | 75.5% | $438.44 Million | $580.55 Million | $142.12 Million | ▼ -7.9 pp |
| 2023 | 83.4% | $438.84 Million | $526.32 Million | $87.48 Million | ▼ -2.8 pp |
| 2022 | 86.2% | $396.15 Million | $459.67 Million | $63.52 Million | ▲ +6.7 pp |
| 2021 | 79.5% | $185.04 Million | $232.80 Million | $47.76 Million | ▼ -9.8 pp |
| 2020 | 89.3% | $311.94 Million | $349.46 Million | $37.53 Million | ▲ +0.7 pp |
| 2019 | 88.6% | $225.42 Million | $254.53 Million | $29.11 Million | ▲ +1.8 pp |
| 2018 | 86.7% | $279.27 Million | $321.96 Million | $42.70 Million | ▲ +275.6 pp |
| 2017 | -188.9% | $-89.71 Million | $47.49 Million | $137.20 Million | ▼ -143.3 pp |
| 2016 | -45.6% | $-25.73 Million | $56.47 Million | $82.20 Million | — |